Lexicon Pharmaceuticals, Inc.
LXRX
$0.3918
$0.02416.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -216.39M | -202.11M | -193.58M | -177.12M | -157.86M |
| Total Depreciation and Amortization | 556.00K | 581.00K | 586.00K | 554.00K | 510.00K |
| Total Amortization of Deferred Charges | 2.06M | 2.28M | 2.03M | 1.77M | 1.50M |
| Total Other Non-Cash Items | 7.75M | 7.06M | 10.90M | 10.24M | 10.79M |
| Change in Net Operating Assets | -1.81M | -3.65M | -5.34M | 2.66M | 12.14M |
| Cash from Operations | -207.84M | -195.84M | -185.41M | -161.90M | -132.92M |
| Capital Expenditure | -557.00K | -333.00K | -222.00K | -470.00K | -1.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.62M | -109.64M | -172.04M | -49.47M | -75.95M |
| Cash from Investing | -17.18M | -109.98M | -172.26M | -49.94M | -77.67M |
| Total Debt Issued | -1.00K | 0.00 | 49.96M | 49.96M | 74.93M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 89.00K | 89.00K | 139.12M | 139.03M | 139.03M |
| Repurchase of Common Stock | -1.73M | -1.94M | -1.94M | -1.04M | -1.10M |
| Issuance of Preferred Stock | 241.43M | 241.43M | 241.43M | -- | -- |
| Repurchase of Preferred Stock | -25.00K | -15.00K | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.31M | -400.00K | -400.00K | -- | -- |
| Cash from Financing | 238.45M | 239.16M | 428.17M | 187.96M | 212.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.44M | -66.65M | 70.49M | -23.88M | 2.28M |
